Intrathecal baclofen use in adults with cerebral palsy

Developmental Medicine and Child Neurology

Volumn 51, Issue SUPPL. 4, 2009, Pages 106-112

  Krach, Linda E ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; BENZODIAZEPINE DERIVATIVE;

ADULT; CEREBRAL PALSY; CLINICAL TRIAL; COGNITION; CONSTIPATION; CONTINUOUS INFUSION; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; DOSE RESPONSE; DRUG COST; DYSTONIA; FATIGUE; HUMAN; IMPOTENCE; INCONTINENCE; INFECTION; LIQUORRHEA; LISTLESSNESS; MUSCLE HYPERTONIA; MUSCLE TONE; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SCOLIOSIS; SIDE EFFECT; SPASTICITY; URINE RETENTION; WITHDRAWAL SYNDROME;

ADULT; BACLOFEN; CATHETERIZATION; CEREBRAL PALSY; HUMANS; INJECTIONS, SPINAL; MUSCLE RELAXANTS, CENTRAL;

EID: 70049117923     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2009.03422.x     Document Type: Review

References (62)

1. Matthews DJ, Wilson P. Cerebral palsy. In: Molnar GE, Alexander MA, editors. Pediatric rehabilitation. 3rd edn. Philadelphia: Hanley & Belfus, 1999: 193-217.
2. Sanger TD, Delgado MR, Gaebler-Spira D, Hallett M, Mink JW, Task Force on Childhood Motor Disorders. Classification and definition of disorders causing hypertonia in childhood. Pediatrics 2003; 111: E89-97.
3. Albright AL. Spastic cerebral palsy: Approaches to drug treatment. CNS Drugs 1995; 4: 17-27.
4. Gilmartin R, Bruce D, Storrs BB, et al. Intrathecal baclofen for management of spastic cerebral palsy: Multicenter trial. J Child Neurol 2000; 15: 71-7.
5. Azouvi P, Mane M, Thiebaut J, Denys P, Remy-Neris O, Bussel B. Intrathecal baclofen administration for control of severe spinal spasticity: Functional improvement and long-term follow-up. Arch Phys Med Rehabil 1996; 77: 35-9.
6. Campbell SK, Almeida GL, Penn RD, Corcos DM. The effects of intrathecally administered baclofen on function in patients with spasticity. Phys Ther 1995; 75: 352-62.
7. Albright AL. Neurosurgical treatment of spasticity and other pediatric movement disorders. J Child Neurol 2003; 18(Suppl 1): S67-78.
8. Scheinberg AM, O'Flaherty S, Chaseling R, Dexter M. Continuous intrathecal baclofen infusion for children with cerebral palsy: A pilot study. J Paediatr Child Health 2001; 37: 283-8.
9. Rawicki B. Treatment of cerebral origin spasticity with continuous intrathecal baclofen delivered via an implantable pump: Long-term follow-up review of 18 patients. J Neurosurg 1999; 91: 733-6.
10. Guillaume D, Van Havenbergh A, Vloeberghs M, Vidal J, Roeste G. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity. Arch Phys Med Rehabil 2005; 86: 2165-71.
11. Hoving MA, van Raak EP, Spincemaille GH, et al. Intrathecal baclofen in children with spastic cerebral palsy: A double-blind, randomized, placebo-controlled, dose-finding study. Dev Med Child Neurol 2007; 49: 654-9.
12. Kolaski K, Logan LR. Intrathecal baclofen in cerebral palsy: A decade of treatment outcomes. J Pediatr Rehabil 2008; 1: 3-32.
13. Krach LE. Pharmacotherapy of spasticity: Oral medications and intrathecal baclofen. J Child Neurol 2001; 16: 31-6.
14. Albright AL, Ferson SS. Intrathecal baclofen therapy in children. Neurosurg Focus 2006; 21: E3.
15. Sgouros S. Surgical management of spasticity of cerebral origin in children. Acta Neurochir Suppl 2007; 97(Pt 1): 193-203.
16. Grabb PA, Guin-Renfroe S, Meythaler JM. Midthoracic catheter tip placement for intrathecal baclofen administration in children with quadriparetic spasticity. Neurosurg 1999; 45: 833-6; discussion 836-7.
17. Krach LE. Rehabilitation following spasticity reduction. In: Gage JR, editor. The Treatment of Gait Problems in Cerebral Palsy. London: Mac Keith Press, 2004: 305-13.
18. Baguley IJ, Bailey KM, Slewa-Younan S. Prolonged anti-spasticity effects of bolus intrathecal baclofen. Brain Inj 2005; 19: 545-8.
19. Krach LE, Kriel RL, Nugent AC. Complex dosing schedules for continuous intrathecal baclofen infusion. Pediatr Neurol 2007; 37: 354-9.
20. Rawlins PK. Intrathecal baclofen therapy over 10 years. J Neurosci Nurs 2004; 36: 322-7.
21. Murphy NA, Irwin MC, Hoff C. Intrathecal baclofen therapy in children with cerebral palsy: Efficacy and complications. Arch Phys Med Rehabil 2002; 83: 1721-5.
22. Albright AL, Ferson S, Carlos S. Occult hydrocephalus in children with cerebral palsy. Neurosurgery 2005; 53: 93-6; discussion 96-7.
23. Fitzgerald JJ, Tsegaye M, Vloeberghs MH. Treatment of childhood spasticity of cerebral origin with intrathecal baclofen: A series of 52 cases. Br J Neurosurg 2004; 18: 240-5.
24. Gooch JL, Oberg WA, Grams B, Ward LA, Walker ML. Complications of intrathecal baclofen pumps in children. Pediatr Neurosurg 2003; 39: 1-6.
25. Stempien L, Tsai T. Intrathecal baclofen pump use for spasticity: A clinical survey. Am J Phys Med Rehabil 2000; 79: 536-41.
26. Gooch JL, Oberg WA, Grams B, Ward LA, Walker ML. Care provider assessment of intrathecal baclofen in children. Dev Med Child Neurol 2004; 46: 548-52.
27. Campbell WM, Ferrel A, McLaughlin JF, et al. Long-term safety and efficacy of continuous intrathecal baclofen. Dev Med Child Neurol 2002; 44: 660-5.
28. Dario A, Scamoni C, Picano M, Casagrande F, Tomei G. Pharmacological complications of the chronic baclofen infusion in the severe spinal spasticity: Personal experience and review of the literature. J of Neurosurg Sci 2004; 48: 177-81.
29. Coffey RJ, Ridgely PM. Abrupt intrathecal baclofen withdrawal: management of potentially life-threatening sequelae. Neuromodulation 2001; 4: 142-6.
30. Coffey RJ, Edgar TS, Francisco GE, et al. Abrupt withdrawal from intrathecal baclofen: Recognition and management of a potentially life-threatening syndrome. Arch Phys Med Rehabil 2002; 83: 735-41.
31. Duhon BS, MacDonald JD. Infusion of intrathecal baclofen for acute withdrawal: Technical note. J Neurosurg 2007; 107: 878-80.
32. Sandstrom K. The lived body-experiences from adults with cerebral palsy. Clin Rehabil 2007; 21: 432-41.
33. Turk MA, Geremski CA, Rosenbaum PF, Weber RJ. The health status of women with cerebral palsy. Arch Phys Med Rehabil 1997; 78: (12 Suppl. 5): S10-17.
34. Murphy KP, Molnar GE, Lankasky K. Medical and functional status of adults with cerebral palsy. Dev Med Child Neurol 1995; 37: 1075-84.
35. Young NL, Gilbert TK, McCormick A, et al. Youth and young adults with cerebral palsy: Their use of physician and hospital services. Arch Phys Med Rehabil 2007; 88: 696-702.
36. Meythaler JM, Guin-Renfroe S, Law C, Grabb P, Hadley MN. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy. Arch Phys Med Rehabil 2001; 82: 155-61.
37. Dario A, Di Stefano MG, Grossi A, Casagrande F, Bono G. Long-term intrathecal baclofen infusion in supraspinal spasticity of adulthood. Acta Neurol Scand 2002; 105: 83-7.
38. Hsieh JC, Penn RD. Intrathecal baclofen in the treatment of adult spasticity. Neurosurg Focus 2006; 21: E5.
39. Remy-Neris O, Tiffreau V, Bouilland S, Bussel B. Intrathecal baclofen in subjects with spastic hemiplegia: Assessment of the antispastic effect during gait. Arch Phys Med Rehabil 2003; 84: 643-50.
40. Horn TS, Yablon SA, Stokic DS. Effect of intrathecal baclofen bolus injection on temporospatial gait characteristics in patients with acquired brain injury. Arch Phys Med Rehabil 2005; 86: 1127-33.
41. Francisco GE, Boake C. Improvement in walking speed in poststroke spastic hemiplegia after intrathecal baclofen therapy: A preliminary study. Arch Phys Med Rehabil 2003; 84: 1194-9.
42. Gerszten PC, Albright AL, Barry MJ. Effect on ambulation of continuous intrathecal baclofen infusion. Pediatr Neurosurg 1997; 27: 40-4.
43. Gerszten PC, Albright AL, Johnstone GF. Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy. J Neurosurg 1998; 88: 1009-13.
44. Staal C, Arends A, Ho S. A self-report of quality of life of patients receiving intrathecal baclofen therapy. Rehabil Nurs 2003; 28: 159-63.
45. Middel B, Kuipers-Upmeijer H, Bouma J, et al. Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity. J Neurol Neurosurg Psychiatry 1997; 63: 204-9.
46. Gianino JM, York MM, Paice JA, Shott S. Quality of life: Effect of reduced spasticity from intrathecal baclofen. J Neurosci Nurs 1998; 30: 47-54.
47. Sampson FC, Hayward A, Evans G, Morton R, Collett B. Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity. J Neurosurg 2002; 96: 1052-7.
48. de Lissovoy G, Matza LS, Green H, Werner M, Edgar T. Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy. J Child Neurol 2007; 22: 49-59.
49. Hoving MA, Evers SM, Ament AJ, van Raak EP, Vles JS, Dutch Study Group on Child Spasticity. Intrathecal baclofen therapy in children with intractable spastic cerebral palsy: A cost-effectiveness analysis. Dev Med Child Neurol 2008; 50: 450-5.
50. Delhaas EM, Verhagen J. Pregnancy in a quadriplegic patient treated with continuous intrathecal baclofen infusion to manage her severe spasticity. Case report. Paraplegia 1992; 30: 527-8.
51. Munoz FC, Marco DG, Perez AV, Camacho MM. Pregnancy outcome in a woman exposed to continuous intrathecal baclofen infusion. Ann Pharmocother 2000; 34: 956.
52. Engrand N, Van de Perre P, Vilain G, Benhamou D. Intrathecal baclofen for severe tetanus in a pregnant woman. Eur J Anaesthesiol 2001; 18: 261-3.
53. Murphy NA. Deep venous thrombosis as a result of hypotonia secondary to intrathecal baclofen therapy: A case report. Arch Phys Med Rehabil 2002; 83: 1311-12.
54. Vender JR, Hester S, Waller JL, Rekito A, Lee MR. Identification and management of intrathecal baclofen pump complications: A comparison of pediatric and adult patients. J Neurosurg 2006; 104(1 Suppl): 9-15.
55. McCarty SF, Gaebler-Spira D, Harvey RL. Improvement of sleep apnea in a patient with cerebral palsy. Am J Phys Med Rehabil 2001; 80: 540-2.
56. Gentilini G, Franchi-Micheli S, Pantalone D, Cortesini C, Zilletti L. GABAB receptor-mediated mechanisms in human intestine in vitro. Eur J Pharmacol 1992; 217: 9-14.
57. Kofler M, Matzak H, Saltuari L. The impact of intrathecal balcofen on gastrointestinal function. Brain Inj 2002; 16: 825-36.
58. Omari TI, Benninga MA, Sansom L, Butler RN, Dent J, Davidson GP. Effect of baclofen on esophagogastric motility and gastroesophageal reflux in children with gastroesophageeal reflux disease: A randomized controlled trial. J Pediatr 2006; 149: 468-74.
59. Krach LE, Kriel RL, Gilmartin RC, et al. Hip status in cerebral palsy after one year of continuous intrathecal baclofen infusion. Pediatr Neurol 2004; 30: 163-8.
60. Ginsburg GM, Lauder AJ. Progression of scoliosis in patients with spastic quadriplegia after insertion of an intrathecal baclofen pump. Spine 2007; 32: 2745-50.
61. Senaran H, Shah SA, Presedo A, Dabney KW, Glutting JW, Miller F. The risk of progression of scoliosis in cerebral palsy patients after intrathecal baclofen therapy. Spine 2007; 32: 2348-54.
62. Lind G, Meyerson BA, Winter J, Linderoth B. Intrathecal baclofen as adjuvant therapy to enhance the effect of spinal cord stimulation in neuropathic pain: A pilot study. Eur J Pain 2004; 8: 377-83.